These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25759633)

  • 41. [Iron intake and HFE gen in male adults from Buenos Aires].
    Felipoff AL; Fleischman SJ; Donadío ML; Sebastiano V; Castro M; Vellicce A; Rey JA; Lardo MM; Langini SH
    Medicina (B Aires); 2017; 77(6):458-464. PubMed ID: 29223935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening for iron overload using transferrin saturation.
    Olsson KS; Eriksson K; Ritter B; Heedman PA
    Acta Med Scand; 1984; 215(2):105-12. PubMed ID: 6702489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Family with marked hyperferritinemia as a result of hemochromatosis type 4 (ferroportin disease)].
    Muehlenberg K; Faltermeier N; Lohse P; Tannapfel A; Pech O
    Z Gastroenterol; 2014 Sep; 52(9):1075-80. PubMed ID: 25198087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic difficulties of primary hemochromatosis in a patient with posthemorrhagic anemia.
    Podzolkov VI; Pokrovskaya AE; Vargina TS; Oganesyan KA
    Ter Arkh; 2019 May; 91(4):118-121. PubMed ID: 31094485
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum transferrin receptor in hereditary hemochromatosis and African siderosis.
    Baynes RD; Cook JD; Bothwell TH; Friedman BM; Meyer TE
    Am J Hematol; 1994 Apr; 45(4):288-92. PubMed ID: 8178799
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of abnormal iron studies in heterozygotes for hereditary hemochromatosis: an analysis of 255 heterozygotes.
    Adams PC
    Am J Hematol; 1994 Feb; 45(2):146-9. PubMed ID: 8141120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy.
    McLaren GD; Muir WA; Kellermeyer RW
    Crit Rev Clin Lab Sci; 1983; 19(3):205-66. PubMed ID: 6373141
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hemochromatosis and Iron Overload Screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults.
    McLaren CE; Barton JC; Adams PC; Harris EL; Acton RT; Press N; Reboussin DM; McLaren GD; Sholinsky P; Walker AP; Gordeuk VR; Leiendecker-Foster C; Dawkins FW; Eckfeldt JH; Mellen BG; Speechley M; Thomson E;
    Am J Med Sci; 2003 Feb; 325(2):53-62. PubMed ID: 12589228
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum soluble transferrin receptor concentrations are increased in central obesity. Results from a screening programme for hereditary hemochromatosis in men with hyperferritinemia.
    Freixenet N; Remacha A; Berlanga E; Caixàs A; Giménez-Palop O; Blanco-Vaca F; Bach V; Baiget M; Sánchez Y; Félez J; González-Clemente JM
    Clin Chim Acta; 2009 Feb; 400(1-2):111-6. PubMed ID: 19000667
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biochemical expression of heterozygous hereditary hemochromatosis.
    de Valk B ; Witlox RS; van der Schouw YT ; Marx JJ
    Eur J Intern Med; 2000 Dec; 11(6):317-321. PubMed ID: 11113655
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Population screening for hemochromatosis: a comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors.
    Adams PC; Kertesz AE; McLaren CE; Barr R; Bamford A; Chakrabarti S
    Hepatology; 2000 May; 31(5):1160-4. PubMed ID: 10796893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hereditary hemochromatosis.
    Holman JR
    J Fam Pract; 1997 Mar; 44(3):304-8. PubMed ID: 9071252
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
    Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
    Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Hereditary hemochromatosis].
    Dantas W
    Rev Gastroenterol Peru; 2001; 21(1):42-55. PubMed ID: 12170286
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Population-based screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri.
    McDonnell SM; Hover A; Gloe D; Ou CY; Cogswell ME; Grummer-Strawn L
    Am J Med; 1999 Jul; 107(1):30-7. PubMed ID: 10403350
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased capacity of lymphocytes from hereditary hemochromatosis patients homozygous for the C282Y HFE mutation to respond to the genotoxic effect of diepoxybutane.
    Porto B; Vieira R; Porto G
    Mutat Res; 2009 Feb; 673(1):37-42. PubMed ID: 19146986
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Survey and clinical application of serum iron, total iron binding capacity, transferrin saturation, and serum ferritin in captive black and white ruffed lemurs (Varecia variegata variegata).
    Crawford GC; Andrews GA; Chavey PS; Dunker FH; Garner MM; Sargent EL
    J Zoo Wildl Med; 2005 Dec; 36(4):653-60. PubMed ID: 17312723
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hereditary hemochromatosis.
    Walker EM; Wolfe MD; Norton ML; Walker SM; Jones MM
    Ann Clin Lab Sci; 1998; 28(5):300-12. PubMed ID: 9784832
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation.
    Gochee PA; Powell LW; Cullen DJ; Du Sart D; Rossi E; Olynyk JK
    Gastroenterology; 2002 Mar; 122(3):646-51. PubMed ID: 11874997
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Screening for iron overload in the Turkish population.
    Barut G; Balci H; Bozdayi M; Hatemi I; Ozcelik D; Senturk H
    Dig Dis; 2003; 21(3):279-85. PubMed ID: 14571105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.